{"id":"NCT01701024","sponsor":"Bausch Health Americas, Inc.","briefTitle":"Clinical Study to Test the Efficacy and Safety of ACYC to Treat Moderate to Severe Acne","officialTitle":"A Phase 3, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, 2-Arm, Parallel Group Comparison Study Comparing the Efficacy and Safety of ACYC and ACYC Vehicle Gel in the Treatment of Acne Vulgaris","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-10","primaryCompletion":"2013-05","completion":"2013-07","firstPosted":"2012-10-04","resultsPosted":"2017-01-10","lastUpdate":"2018-06-04"},"enrollment":498,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Acne"],"interventions":[{"type":"DRUG","name":"ACYC","otherNames":[]},{"type":"DRUG","name":"ACYC vehicle","otherNames":[]}],"arms":[{"label":"ACYC","type":"ACTIVE_COMPARATOR"},{"label":"ACYC vehicle","type":"PLACEBO_COMPARATOR"}],"summary":"The primary objective of this study is to compare the efficacy and safety and tolerability of ACYC Gel and vehicle in the treatment of subjects with Acne Vulgaris.","primaryOutcome":{"measure":"Absolute Change in Inflammatory Lesion Count","timeFrame":"Baseline and 12 Weeks","effectByArm":[{"arm":"ACYC","deltaMin":16.3,"sd":9.75},{"arm":"ACYC Vehicle","deltaMin":8.2,"sd":11.55}],"pValues":[]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":2},"locations":{"siteCount":24,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":243},"commonTop":["Nasopharyngitis","Influenza","Headache","Sinusitis","Pyrexia"]}}